Futura Medical plc
FAMDF
$0.15
$0.017.14%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.43M | 4.51M | 4.42M | 4.44M | 868.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.43M | 4.51M | 4.42M | 4.44M | 868.00K |
| Cost of Revenue | 1.32M | 1.34M | 1.38M | 1.38M | 330.60K |
| Gross Profit | 3.12M | 3.17M | 3.04M | 3.06M | 537.30K |
| SG&A Expenses | 2.20M | 2.24M | 2.14M | 2.15M | 2.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -81.70K | -83.00K | -- | -- | -- |
| Total Operating Expenses | 4.16M | 4.23M | 3.90M | 3.92M | 3.98M |
| Operating Income | 271.60K | 276.00K | 517.00K | 519.70K | -3.11M |
| Income Before Tax | 271.60K | 276.00K | 546.60K | 549.50K | -3.06M |
| Income Tax Expenses | 85.10K | 86.40K | -85.20K | -85.60K | -111.20K |
| Earnings from Continuing Operations | 186.60K | 189.60K | 631.80K | 635.10K | -2.95M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 186.60K | 189.60K | 631.80K | 635.10K | -2.95M |
| EBIT | 271.60K | 276.00K | 517.00K | 519.70K | -3.11M |
| EBITDA | 311.60K | 316.60K | 554.50K | 557.40K | -3.07M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 |
| Average Basic Shares Outstanding | 302.73M | 302.73M | 301.50M | 301.50M | 300.85M |
| Average Diluted Shares Outstanding | 304.10M | 304.10M | 317.44M | 317.44M | 300.85M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |